AINewsnow

Proteomic Aging Clocks Track Biological Age Reversal in Rentosertib Trial

This story is from 2026-09-07. It is preserved in the archive; the latest stories are on the live feed.

Researchers from Insilico Medicine and an international group of academic collaborators have applied six independently developed proteomic aging clocks to blood samples from a Phase IIa trial of the AI-designed drug rentosertib, finding that all six models consistently predicted lower biological ag…

Read the full story at Unite.AI ↗

Timeline · 1 report

  1. 2026-09-07 09:58 · Unite.AI
    Proteomic Aging Clocks Track Biological Age Reversal in Rentosertib Trial

More stories

  1. Introducing Kimi K3 on Amazon Bedrock — AWS Machine Learning Blog
  2. Introducing Amazon SageMaker HyperPod Inference Gateway — AWS Machine Learning Blog
  3. Anthropic, OpenAI, SpaceXAI, Google sued over call to ‘pace’ AI development — Politico Technology
  4. Gemini Hacked Three Companies in First Known Breakout by Google’s AI — Wall Street Journal Technology
  5. NVIDIA CEO Jensen Huang rejects ‘AI will end the world’ claim, yet cautions ‘we should go as fast as we can but...’ — Mint AI
  6. AI hallucination of Chinese nuclear components almost led to US military attack — Ars Technica AI
  7. The new AgentCore runtime: Elastic, optimized, and consistently fast starts — AWS Machine Learning Blog
  8. Qwen Image 2.1 PR to ComfyUI — r/StableDiffusion

Get the daily brief of stories like this at 6:30 every morning →